Narrative Update • Aug 05
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedAug 07, 2026
DataAggregated Company Financials
Companies9
- 7D1.7%
- 3M29.2%
- 1Y56.8%
- YTD23.3%
Over the last 7 days, the Pharma industry has risen 1.7%, driven by gains in Merck KGaA and Bayer of 1.6% and 2.0%, respectively. This means that the industry has gained 57% over the past year. Looking forward, earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 07 Aug 2026 | €115.2b | €67.6b | €900.5m | 24.9x | 127.9x | 1.7x |
| Sun, 05 Jul 2026 | €118.9b | €67.4b | €482.6m | 25x | 246.4x | 1.8x |
| Tue, 02 Jun 2026 | €96.0b | €67.4b | €482.2m | 22.5x | 199x | 1.4x |
| Thu, 30 Apr 2026 | €85.7b | €67.9b | -€888,694,240.91 | 17.6x | -96.4x | 1.3x |
| Sat, 28 Mar 2026 | €86.5b | €67.9b | -€900,266,675.63 | 18.6x | -96x | 1.3x |
| Mon, 23 Feb 2026 | €101.4b | €68.3b | €2.9b | 18.5x | 35.4x | 1.5x |
| Wed, 21 Jan 2026 | €99.5b | €68.3b | €2.9b | 17.6x | 34.7x | 1.5x |
| Fri, 19 Dec 2025 | €89.3b | €68.3b | €2.9b | 17.4x | 31.2x | 1.3x |
| Sun, 16 Nov 2025 | €82.1b | €68.5b | €2.9b | 18.4x | 28.5x | 1.2x |
| Tue, 14 Oct 2025 | €81.5b | €68.8b | -€439,003,142.76 | 19.1x | -185.5x | 1.2x |
| Thu, 11 Sep 2025 | €77.8b | €68.9b | -€406,214,491.93 | 16.9x | -191.6x | 1.1x |
| Sat, 09 Aug 2025 | €75.3b | €69.0b | -€454,993,067.13 | 16.9x | -165.5x | 1.1x |
| Mon, 07 Jul 2025 | €76.6b | €69.4b | -€283,071,598.00 | 17.7x | -270.6x | 1.1x |
| Wed, 04 Jun 2025 | €77.0b | €69.4b | -€206,268,848.00 | 17.9x | -373.3x | 1.1x |
| Fri, 02 May 2025 | €78.3b | €69.3b | €463.1m | 18.7x | 169x | 1.1x |
| Sun, 30 Mar 2025 | €81.5b | €69.2b | €436.0m | 20.4x | 187x | 1.2x |
| Tue, 25 Feb 2025 | €84.3b | €69.2b | €2.0b | 22.1x | 41.6x | 1.2x |
| Thu, 23 Jan 2025 | €86.6b | €69.2b | €2.0b | 23.3x | 43.1x | 1.3x |
| Sat, 21 Dec 2024 | €81.3b | €69.2b | €2.0b | 22.3x | 40.5x | 1.2x |
| Mon, 18 Nov 2024 | €84.7b | €69.2b | €2.0b | 20.7x | 41.8x | 1.2x |
| Wed, 16 Oct 2024 | €96.5b | €69.4b | €1.6b | 20.7x | 61.8x | 1.4x |
| Fri, 13 Sep 2024 | €101.9b | €69.3b | €1.5b | 24.6x | 69.1x | 1.5x |
| Sun, 11 Aug 2024 | €100.1b | €69.3b | €1.5b | 30.4x | 68.7x | 1.4x |
| Tue, 09 Jul 2024 | €93.8b | €69.2b | -€303,627,757.00 | 29.2x | -309x | 1.4x |
| Thu, 06 Jun 2024 | €105.0b | €69.2b | -€328,028,608.00 | 20.2x | -320.2x | 1.5x |
| Sat, 04 May 2024 | €96.1b | €70.0b | -€63,332,221.67 | 20.1x | -1517.1x | 1.4x |
| Mon, 01 Apr 2024 | €101.4b | €70.0b | -€34,208,180.00 | 21.4x | -2964.4x | 1.4x |
| Wed, 28 Feb 2024 | €99.9b | €70.6b | -€650,504,143.00 | 19.1x | -153.5x | 1.4x |
| Fri, 26 Jan 2024 | €98.7b | €70.6b | -€647,396,793.00 | 21.6x | -152.4x | 1.4x |
| Sun, 24 Dec 2023 | €96.3b | €70.6b | -€650,606,256.00 | 19.4x | -148x | 1.4x |
| Tue, 21 Nov 2023 | €106.0b | €70.6b | -€653,407,256.00 | 19.2x | -162.3x | 1.5x |
| Thu, 19 Oct 2023 | €107.6b | €72.1b | €4.7b | 18.8x | 23x | 1.5x |
| Sat, 16 Sep 2023 | €122.6b | €72.1b | €4.7b | 21.3x | 26.2x | 1.7x |
| Mon, 14 Aug 2023 | €125.6b | €72.1b | €4.7b | 23.1x | 26.8x | 1.7x |
Price to Earnings Ratio
26.8x
Current Industry PE
- Investors are pessimistic on the German Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 128x which is lower than its 3-year average PE of 140x.
- The 3-year average PS ratio of 1.3x is lower than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 42% per year over the last three years,
- Revenues have also declined 2.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 1.54% | |
| Healthcare | 2.03% | |
| Pharma | 1.67% | |
| Pharma | 1.67% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €49.81 | 3.7% +€1.7b | 93.7% | PS1.1x | |
| 93M1 MPH Health Care | €24.10 | 0.8% +€856.3k | 37.7% | PS2.1x | |
| B8FK Biofrontera | €2.60 | 3.2% +€486.1k | -4.1% | PS1.2x | |
| 27N0 Cannovum Cannabis | €0.49 | 15.0% +€147.9k | 126.7% | n/a | |
| SBX SynBiotic | €1.10 | 1.5% +€109.2k | -63.4% | n/a |
